Weidejie Bio

Weidejie Bio

伟德杰生物

Weidejie Bio

Biotech/Healthcare

Weidejie Biotech is a platform company focused on developing innovative antibody therapies for autoimmune diseases. It has proprietary platforms for antibody screening and optimization, fusion protein CMC, and in vitro activity evaluation.

Latest round: Series C (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-06-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.